July 2020 Bite Me Cancer Has Chosen It’s 7th Thyroid Cancer Research Grant

August 5, 2020

By Sharon Ferraro

July 2020 – Bite Me Cancer chosen a grant directed by Dr. Cristina Montero-Conde, PhD, Spanish National Cancer Research Center (CNIO), Madrid, Spain, entitled “Discovering novel molecular nodes involved in MTC development and evolution.” This research project has the potential to identify molecular events that confer an outgrowth advantage to the tumor but at the same time a greater dependence on specific oncogenes or molecular networks. Therefore, such alterations could predict enhanced responses to selective molecules, such as the RET-targeted inhibitors Blu-667 (submitted for FDA approval) and LOXO-292 (recently FDA approved. In addition, the results of this proposal will generate the first map of allelic imbalance events in MTC.